Remove solution clinical-development
article thumbnail

Biofourmis announces major agreements with top pharmaceutical companies

Digital Health Global

Biofourmis , a global digital health and clinical trial solutions leader, announces four key partnerships with top pharmaceutical firms. Beyond digital biomarker and endpoint expertise, pharmaceutical partners are leveraging Biofourmis to streamline study timelines through its Digital Clinical Trials solution.

article thumbnail

Huma acquires Alcedis to expand clinical trial platform

Mobi Health News

The UK-based company will form an advanced clinical trials division offering digital health solutions for each phase of the development process.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Orion Corporation and Newel Health enter into licensing agreement for a digital therapeutic (DTx) ODD-403 (“Rohkea”) in pain

Digital Health Global

Orion Corporation (“Orion”) and Newel Health (“Newel”) have entered into a license agreement regarding ODD-403 (“Rohkea”), a digital therapeutic (DTx) developed by Orion for patients suffering from chronic pain and particularly from fear of movement and re-injury. The core therapy areas of our pharmaceutical R&D are oncology and pain.

article thumbnail

A Gartner expert points to AI and hospital-at-home as the biggest emerging technologies at HIMSS24

Healthcare IT News - Telehealth

Veronica Walk is senior director analyst, healthcare and life sciences, at consulting firm Gartner, where she specializes in emerging clinical technologies. You specialize in emerging clinical technologies. What has been the most important emerging clinical technology you've seen at HIMSS24 this week, and why is it so important?

Nursing 204
article thumbnail

Tris Pharma Launches Digital Health Business to Develop and Commercialize Digital Products for ADHD

Digital Health Global

– Tris Digital Health enters into licensing agreement with Braingaze to develop and commercialize first-in-class, AI-enhanced technology that offers healthcare professionals an objective tool to improve accuracy of ADHD diagnosis – – Tris will conduct U.S. clinical trials to validate Braingaze technology ahead of commercialization in the U.S.

article thumbnail

Neurable Inc. and Healthspan Digital Inc. Announce Partnership to Empower Precision Health and Longevity Clinics with Brain-Computer Interface Technologies

Digital Health Global

a leading developer of brain-computer interface (BCI) technology, and Healthspan Digital Inc., a Canadian HealthTech in precision health and longevity solutions, are thrilled to announce their collaboration to commercialize Neurable’s advanced brain health tools. TORONTO–(BUSINESS WIRE)–Neurable Inc., ” Dr.

article thumbnail

Four Steps to Success in Implementing AI Within Healthcare Organizations

Healthcare IT Today

The system records the conversation between clinician and patient, and then automatically produces a clinical note. It produces the clinical note in near real-time, so the clinician can review it and make any necessary edits at the time of the encounter. AI can then translate the clinical concepts into standard formats.